NYSE:BUD • US03524A1088
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANHEUSER-BUSCH INBEV-SPN ADR (BUD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-19 | Wells Fargo | Initiate | Overweight |
| 2025-05-12 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-01-08 | TD Cowen | Maintains | Hold -> Hold |
| 2024-10-08 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-10-01 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-09-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-07-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-05 | TD Cowen | Maintains | Outperform -> Outperform |
| 2024-01-12 | Exane BNP Paribas | Downgrade | Outperform -> Neutral |
| 2024-01-10 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-29 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-07-20 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-06-22 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2023-06-08 | Evercore ISI Group | Maintains | Outperform |
| 2021-11-19 | Redburn Partners | Upgrade | Neutral -> Buy |
| 2021-09-30 | Argus Research | Downgrade | Buy -> Hold |
| 2021-09-02 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 59.38B 2.76% | 59.768B 0.65% | 59.32B -0.75% | 64.072B 8.01% | 66.425B 3.67% | 68.865B 3.67% | 71.984B 4.53% | 75.705B 5.17% | 73.763B -2.57% | 75.859B 2.84% | |
| EBITDA YoY % growth | 19.884B 1.64% | 20.918B 5.20% | 21.411B 2.36% | 23.251B 8.59% | 24.512B 5.42% | 25.613B 4.49% | 26.783B 4.57% | 28.189B 5.25% | N/A | N/A | |
| EBIT YoY % growth | 14.473B -0.08% | 15.374B 6.23% | 15.759B 2.50% | 17.718B 12.43% | 18.88B 6.56% | 19.723B 4.47% | 20.862B 5.77% | 22.577B 8.22% | N/A | N/A | |
| Operating Margin | 24.37% | 25.72% | 26.57% | 27.65% | 28.42% | 28.64% | 28.98% | 29.82% | N/A | N/A | |
| EPS YoY % growth | 3.32 -3.17% | 3.82 15.08% | 4.06 6.27% | 4.69 15.46% | 5.27 12.35% | 5.84 10.92% | 6.54 11.88% | 7.41 13.38% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.99 11.72% | 1.20 12.13% | 1.26 16.59% | 1.25 21.11% |
| Revenue Q2Q % growth | 14.879B 9.18% | 16.332B 8.85% | 16.234B 7.28% | 16.54B 6.33% |
| EBITDA Q2Q % growth | 5.308B 9.53% | 5.839B -11.45% | 6.158B 11.34% | 6.1B -37.13% |
| EBIT Q2Q % growth | 3.915B 9.14% | 4.411B 9.92% | 4.672B 11.11% | 4.579B 13.06% |
All data in USD
33 analysts have analysed BUD and the average price target is 89.86 USD. This implies a price increase of 23.82% is expected in the next year compared to the current price of 72.57.
ANHEUSER-BUSCH INBEV-SPN ADR (BUD) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of ANHEUSER-BUSCH INBEV-SPN ADR (BUD) is 0.99 USD and the consensus revenue estimate is 14.88B USD.
The consensus rating for ANHEUSER-BUSCH INBEV-SPN ADR (BUD) is 80.6061 / 100 . This indicates that analysts generally have a positive outlook on the stock.